Insect larvae-based feed additive/vaccine maker shifts focus to farmed shrimp These trays show R&D scale growth conditions for the insect larvae VakSea uses to produce its immune-boosting proteins. Courtesy photo. Vaccinating aquatic animals is a time- and labor-intensive activity that also comes at great cost to aquaculture operators, most of whom would prefer to avoid…
When: Thursday, September 20, 2018 4:00 – 7:00 PM EST
Where: Columbus Center 701 E Pratt St Baltimore, MD 21202
Join us in envisioning a future that weaves together big data scientists with makers, medical doctors with apparel designers, cut & sew craftsman with artificial intelligence coders. An evening of looking back on the textile mills that once built our city and seeing the new mills of tomorrow filled with smart garments, technical textiles and wearables. Visit the displays of Baltimore companies with athletic apparel, high fashion and medical devices made with functional textiles. Most importantly, see how this new fabric of Baltimore engages you.
Silver Spring-based United Therapeutics Corp. announced Tuesday that it will pay a California company $95 million to develop a new form and delivery method of its flagship Remodulin drug to treat pulmonary arterial hypertension.
BrainScope today announced that it has been awarded a research contract by the United States Department of Defense (DOD) valued at $4.5 million to create and integrate ocular capabilities into its handheld, multi-parameter mild Traumatic Brain Injury (mTBI) and concussion products.
In healthcare, immersive technology has a number of benefits. Many of these have been demonstrated in a number of ways, whether that is through distracting from pain, or helping to train new doctors. One of the most promising is how virtual reality (VR) can assist in surgery. This technology is being introduced to the Children’s National Health System in Washington D.C.
You have one week left to submit your proposal for our $100K pediatric pitch competition focused on pediatric cardiovascular devices that meet a significant unmet need. The submission deadline is Sept. 10.
If chosen as a finalist, you will have an opportunity to pitch your device to our distinguished panel of judges on Sept. 23 as part of our annual pediatric device symposium.
A new space designed to promote student entrepreneurship is open near Johns Hopkins University’s Homewood campus as the school welcomes students back to campus this week.
A George Mason University researcher is heading a scientific team that has received a sizable Department of Defense grant to combat the threat of a South American disease that can cause long-term neurological problems and even death.
Orthopedics company Stryker announced Thursday that it is buying K2M Group Holdings, a maker of 3-D printed implantable, minimally invasive spine products, for $1.4 billion. Analysts reacted positively pointing out that while a small player K2M will help to boost Stryker’s spine division that has not been performing well as of late.
When: Thursday, September 6, 2018 from 4:30 PM to 7:30 PM EDT
Where: Columbus Center – Baltimore 701 E Pratt St Baltimore, MD 21202
Join us for this exclusive CEO Talks panel event on September 6th in Baltimore!
The second installment of the #CEOTalks event series will bring you insights from local company executives on the game changing technologies they are bringing to market to address one of the greatest public health threats of our age; Anti-microbial Resistance (AMR).
Bringing new treatments to market in this field is made harder by a unique set of market conditions and investment hurdles that executives need to navigate to be successful.
